Quarterly Financial Data (Tables)

12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information [Table Text Block]

respectively.

	Three Months Ended
(in thousands, except per share data)	March 31, 2015			June 30, 2015			September 30, 2015			December 31, 2015
Revenues	$	3,172		$	5,867		$	5,888		$	7,560
Total operating costs and expenses	$	21,260		$	31,536		$	16,271		$	67,269
Net loss	$	(19,231	)	$	(17,158	)	$	(11,393	)	$	(33,228	)
Net loss attributable to Caladrius Biosciences, Inc. common stockholders	$	(19,187	)	$	(17,126	)	$	(11,376	)	$	(33,197	)
Basic and diluted loss per share attributable to Caladrius Biosciences, Inc. common stockholders	$	(0.51	)	$	(0.38	)	$	(0.21	)	$	(0.59	)

	Three Months Ended
(in thousands, except per share data)	March 31, 2014			June 30, 2014			September 30, 2014			December 31, 2014
Revenues	$	4,056		$	4,489		$	4,118		$	5,276
Total operating costs and expenses	$	17,555		$	16,919		$	20,376		$	20,830
Net loss	$	(13,830	)	$	(12,769	)	$	(17,177	)	$	(11,691	)
Net loss attributable to Caladrius Biosciences, Inc. common stockholders	$	(13,682	)	$	(12,605	)	$	(16,974	)	$	(11,612	)
Basic and diluted loss per share attributable to Caladrius Biosciences, Inc. common stockholders	$	(0.49	)	$	(0.40	)	$	(0.48	)	$	(0.32	)